MYREXIS INC (MYRX)

Overview Price 2.81 Price Change Today -$0.02 (-0.71%) P&P rating Zacks Rank N/A - N/A Open Price $2.82 Previous Close $2.83 Daily Range $2.80 - $2.85 52-Week Range $2.41 - $4.52 Volume 20,753 Myrexis, Inc., formerly known as Myriad Pharmaceuticals, Inc., is a biotechnology company focused on discovering, developing, and commercializing novel therapies for the treatment of cancer. The Company's product pipeline includes Azixa (verubulin, MPC-6827), a microtubule destabilizer for brain cancer; MPC-3100, an HSP90 inhibitor for cancer; MPC-9528, a Cancer Metabolism Inhibitor; MPI-485520, an IKK inhibitor for cancer and inflammation; and others. Myriad Pharmaceuticals, Inc. is based in Salt Lake City, Utah. Other Resources for MYRX Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. Myrexis, Inc., formerly known as Myriad Pharmaceuticals, Inc., is a biotechnology company focused on discovering, developing, and commercializing novel therapies for the treatment of cancer. The Company's product pipeline includes Azixa (verubulin, MPC-6827), a microtubule destabilizer for brain cancer; MPC-3100, an HSP90 inhibitor for cancer; MPC-9528, a Cancer Metabolism Inhibitor; MPI-485520, an IKK inhibitor for cancer and inflammation; and others. Myriad Pharmaceuticals, Inc. is based in Salt Lake City, Utah.   No brokerage coverage for MYRX   MYRX Ratings: BUY  SELL  HOLD MYRX Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 1 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	06/04/10	Hospira-Javelin Merger in Trouble - Analyst Blog	0
Zacks_Analysts	0.00	05/20/10	Hospira Extends Javelin Offer - Analyst Blog	0
Zacks_Analysts	0.00	04/20/10	Hospira to Acquire Javelin Pharma - Analyst Blog	0
Zacks_Analysts	0.00	08/26/09	Myriad Reports Strong Revenues - Analyst Blog	0

Commentary

BUY: MYRIAD PHARMACEUTICALS INC (MYRX) Start Price: $6.29 Points: -80.37 Created: 10/24/2009 Comments: 0 | Comment poconobear Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
poconobear	95.08	BUY	Six Months to a Year	10/24/2009	$6.29	$2.82 (-0.70%)	-55.17%	+25.20%	-80.37